Distinct differences in gut microbial composition and functional potential from lean to morbidly obese subjects

Area of Science:

• Microbiome research
• Metagenomics
• Obesity research

Background:

• The gut microbiome's role in obesity is increasingly recognized.
• Large-scale studies on microbiome variation across a wide BMI range are limited.
• Understanding the gut microbiome's contribution to obesity-related phenotypes is crucial.

Purpose of the Study:

• To investigate the fecal microbial metagenome's ability to explain variance in clinical phenotypes associated with morbid obesity.
• To determine if gut microbiome composition can distinguish between individuals with and without obesity.
• To explore associations between gut microbial metabolism and obesity markers.

Main Methods:

• Shotgun metagenomic sequencing of fecal samples from 177 Caucasian subjects (82 without obesity, 95 with obesity).
• Analysis of microbial composition and metabolic pathways.
• Application of machine learning models to assess microbiome's explanatory power for clinical phenotypes.

Main Results:

• Distinct differences in microbial composition and metabolic pathways were observed between obese and non-obese subjects.
• 52 bacterial species showed significant variation between the groups.
• Microbial amino acid biosynthesis pathways were enriched in obese subjects, while degradation pathways were depleted.
• Machine learning models indicated the gut microbiome explained over 50% of the variance in body fat composition and BMI.

Conclusions:

• Fecal microbiota composition effectively distinguishes individuals with and without obesity.
• Strong associations exist between gut microbial amino acid metabolism, specific microbial species, and clinical features of obesity.